Attention‑Deficit / Hyperactivity Disorder in Children: Overcoming Diagnostic Challenges and Exploring Modern Treatment Approaches
DOI:
https://doi.org/10.12775/QS.2025.46.66626Keywords
Attention-Deficit / Hyperactivity Disorder, ADHD, diagnostic challenges, symptoms managements, stimulant medication, non-stimulant medication, multimodal treatmentAbstract
Attention-Deficit / Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder with significant functional impact. It is characterized by inattention, hyperactivity, and impulsivity. Its diagnosis remains challenging due to informant discrepancies, developmental variations, and gender- or culture-related biases. Disparities in healthcare access and stigma further contribute to under- and over-diagnosis, particularly in marginalized populations.This narrative review synthesizes recent literature on advances in ADHD assessment and management. Structured diagnostic tools, digital health innovations, and equity-aware algorithm design are emerging as promising solutions to improve accuracy and reduce bias. In Europe, methylphenidate remains the most commonly prescribed first-line treatment, supported by robust evidence for symptom reduction. Non-stimulant options, such as atomoxetine, guanfacine, and clonidine, provide alternatives for patients with contraindications or poor tolerance to stimulants.
Beyond pharmacology, evidence-based psychosocial interventions; including Parent Management Training (PMT) and Cognitive Behavioral Therapy (CBT), play a critical role in promoting long-term functional outcomes. Lifestyle modifications, particularly structured physical activity and dietary interventions, e.g., balanced nutrition, omega-3 supplementation, show benefits in symptom management. The expansion of telemedicine and digital platforms has enhanced care delivery, enabling remote monitoring, parent training, and behavioral support in underserved areas.
Effective ADHD care requires an individualized, developmentally sensitive, and culturally competent approach that integrates medical, psychological, and social dimensions. Continued research into digital diagnostics, bias mitigation, and personalized treatment pathways will be essential to ensure equitable, accessible, and comprehensive care.
References
[1] I. Rocco, B. Corso, M. Bonati, and N. Minicuci, ‘Time of onset and/or diagnosis of ADHD in European children: a systematic review’, BMC Psychiatry, vol. 21, p. 575, Nov. 2021, doi: 10.1186/s12888-021-03547-x.
[2] R. Drechsler, S. Brem, D. Brandeis, E. Grünblatt, G. Berger, and S. Walitza, ‘ADHD: Current Concepts and Treatments in Children and Adolescents’, Neuropediatrics, vol. 51, no. 5, pp. 315–335, Oct. 2020, doi: 10.1055/s-0040-1701658.
[3] S. Young et al., ‘The ADHD Assessment Quality Assurance Standard for Children and Teenagers (CAAQAS)’, Neuropsychiatr. Dis. Treat., vol. Volume 20, pp. 2603–2628, Dec. 2024, doi: 10.2147/ndt.s472923.
[4] F. D. Mowlem, M. A. Rosenqvist, J. Martin, P. Lichtenstein, P. Asherson, and H. Larsson, ‘Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment’, Eur. Child Adolesc. Psychiatry, vol. 28, no. 4, pp. 481–489, 2019, doi: 10.1007/s00787-018-1211-3.
[5] L. Kazda, K. Bell, R. Thomas, K. McGeechan, R. Sims, and A. Barratt, ‘Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents’, JAMA Netw. Open, vol. 4, no. 4, p. e215335, Apr. 2021, doi: 10.1001/jamanetworkopen.2021.5335.
[6] F. Abhishek et al., ‘Dietary Interventions and Supplements for Managing Attention-Deficit/Hyperactivity Disorder (ADHD): A Systematic Review of Efficacy and Recommendations’, Cureus, vol. 16, no. 9, p. e69804, doi: 10.7759/cureus.69804.
[7] S. Sadr-Salek, A. P. Costa, and G. Steffgen, ‘Psychological Treatments for Hyperactivity and Impulsivity in Children with ADHD: A Narrative Review’, Children, vol. 10, no. 10, p. 1613, Sept. 2023, doi: 10.3390/children10101613.
[8] P. C. Ford-Jones, ‘Misdiagnosis of attention deficit hyperactivity disorder: “Normal behaviour” and relative maturity’, Paediatr. Child Health, vol. 20, no. 4, pp. 200–202, May 2015, doi: 10.1093/pch/20.4.200.
[9] F. Castellano-García, A. Benito, A. Jovani, A. Fuertes-Sáiz, M. I. Marí-Sanmillán, and G. Haro, ‘Sex Differences in Substance Use, Prevalence, Pharmacological Therapy, and Mental Health in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)’, Brain Sci., vol. 12, no. 5, p. 590, May 2022, doi: 10.3390/brainsci12050590.
[10] A. Feng, S. O’Neill, and A. L. Rostain, ‘Contributors to Underdiagnosis of ADHD among Asian Americans: A Narrative Review’, J. Atten. Disord., vol. 28, no. 12, pp. 1499–1519, Oct. 2024, doi: 10.1177/10870547241264113.
[11] P. L. Morgan, A. D. Woods, and Y. Wang, ‘Sociodemographic Disparities in Attention-Deficit/Hyperactivity Disorder Overdiagnosis and Overtreatment During Elementary School’, J. Learn. Disabil., vol. 56, no. 5, pp. 359–370, June 2022, doi: 10.1177/00222194221099675.
[12] U. Klefsjö, A. K. Kantzer, C. Gillberg, and E. Billstedt, ‘The road to diagnosis and treatment in girls and boys with ADHD – gender differences in the diagnostic process’, Nord. J. Psychiatry, vol. 75, no. 4, pp. 301–305, May 2021, doi: 10.1080/08039488.2020.1850859.
[13] M.-C. Brault, E. Degroote, M. Jean, and M. Van Houtte, ‘Relative Age Effect in Attention Deficit/Hyperactivity Disorder at Various Stages of the Medicalization Process’, Children, vol. 9, no. 6, Art. no. 6, June 2022, doi: 10.3390/children9060889.
[14] E. Frisira, J. Holland, and K. Sayal, ‘Systematic review and meta-analysis: relative age in attention-deficit/ hyperactivity disorder and autism spectrum disorder’, Eur. Child Adolesc. Psychiatry, vol. 34, no. 2, pp. 381–401, 2025, doi: 10.1007/s00787-024-02459-x.
[15] T. Takeda, J. Nissley-Tsiopinis, S. Nanda, and R. Eiraldi, ‘Factors Associated With Discrepancy in Parent–Teacher Reporting of Symptoms of ADHD in a Large Clinic-Referred Sample of Children’, J. Atten. Disord., vol. 24, no. 11, pp. 1605–1615, Sept. 2020, doi: 10.1177/1087054716652476.
[16] C. E. Yeguez and M. H. Sibley, ‘Predictors of Informant Discrepancies Between Mother and Middle School Teacher ADHD Ratings’, School Ment. Health, vol. 8, no. 4, pp. 452–460, Dec. 2016, doi: 10.1007/s12310-016-9192-1.
[17] C. M. Jungersen and C. J. Lonigan, ‘Do Parent and Teacher Ratings of ADHD Reflect the Same Constructs? A Measurement Invariance Analysis’, J. Psychopathol. Behav. Assess., vol. 43, no. 4, pp. 778–792, Dec. 2021, doi: 10.1007/s10862-021-09874-3.
[18] B. French, K. Sayal, and D. Daley, ‘Barriers and facilitators to understanding of ADHD in primary care: a mixed-method systematic review’, Eur. Child Adolesc. Psychiatry, vol. 28, no. 8, pp. 1037–1064, 2019, doi: 10.1007/s00787-018-1256-3.
[19] K. Jelinkova, E. Charabin, C. Miller, and E. A. Climie, ‘Self-Stigma of Canadian Youth With ADHD and Their Parents’, J. Atten. Disord., vol. 28, no. 12, pp. 1598–1611, Oct. 2024, doi: 10.1177/10870547241273161.
[20] R. Schoeman and T. Voges, ‘Attention-deficit hyperactivity disorder stigma: The silent barrier to care’, South Afr. J. Psychiatry SAJP J. Soc. Psychiatr. South Afr., vol. 28, p. 1865, Dec. 2022, doi: 10.4102/sajpsychiatry.v28i0.1865.
[21] S. dosReis, C. L. Barksdale, A. Sherman, K. Maloney, and A. Charach, ‘Stigmatizing Experiences of Parents of Children With a New Diagnosis of ADHD’, Psychiatr. Serv., vol. 61, no. 8, pp. 811–816, Aug. 2010, doi: 10.1176/ps.2010.61.8.811.
[22] J. L. Ohan, T. A. W. Visser, R. G. Moss, and N. B. Allen, ‘Parents’ Stigmatizing Attitudes Toward Psychiatric Labels for ADHD and Depression’, Psychiatr. Serv., vol. 64, no. 12, pp. 1270–1273, Dec. 2013, doi: 10.1176/appi.ps.201200578.
[23] B. S. Peterson et al., ‘Tools for the Diagnosis of ADHD in Children and Adolescents: A Systematic Review’, Pediatrics, vol. 153, no. 4, p. e2024065854, Mar. 2024, doi: 10.1542/peds.2024-065854.
[24] F. Abedinzadeh Torghabeh, Y. Modaresnia, and S. A. Hosseini, ‘EEG-Based Effective Connectivity Analysis for Attention Deficit Hyperactivity Disorder Detection Using Color-Coded Granger-Causality Images and Custom Convolutional Neural Network’, Int. Clin. Neurosci. J., vol. 10, p. e12, Nov. 2023, doi: 10.34172/icnj.2023.12.
[25] H. W. Loh, C. P. Ooi, P. D. Barua, E. E. Palmer, F. Molinari, and U. R. Acharya, ‘Automated detection of ADHD: Current trends and future perspective’, Comput. Biol. Med., vol. 146, p. 105525, July 2022, doi: 10.1016/j.compbiomed.2022.105525.
[26] Z. Zakani, H. Moradi, S. Ghasemzadeh, M. Riazi, and F. Mortazavi, ‘The Validity of a Machine Learning-Based Video Game in the Objective Screening of Attention Deficit Hyperactivity Disorder in Children Aged 5 to 12 Years’, Dec. 19, 2023, arXiv: arXiv:2312.11832. doi: 10.48550/arXiv.2312.11832.
[27] X. Zhao, T. Hayes, A. C. Timmons, W. Wu, and S. L. Frazier, ‘Unpacking Inequities in ADHD Diagnosis: Examining Individual-Level Race/Ethnicity and State-Level Online Information-Seeking Patterns’, Adm. Policy Ment. Health Ment. Health Serv. Res., vol. 50, no. 4, pp. 576–590, July 2023, doi: 10.1007/s10488-023-01259-w.
[28] F. L. Cibrian, E. M. Monteiro, and K. D. Lakes, ‘Digital assessments for children and adolescents with ADHD: a scoping review’, Front. Digit. Health, vol. 6, Oct. 2024, doi: 10.3389/fdgth.2024.1440701.
[29] B. T. Felt, B. Biermann, J. G. Christner, P. Kochhar, and R. V. Harrison, ‘Diagnosis and Management of ADHD in Children’, Accessed: July 23, 2025. [Online]. Available: https://www.aafp.org/pubs/afp/issues/2014/1001/p456.html
[30] S. Cortese et al., ‘Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis’, Lancet Psychiatry, vol. 5, no. 9, pp. 727–738, Sept. 2018, doi: 10.1016/S2215-0366(18)30269-4.
[31] K. A. Brown, S. Samuel, and D. R. Patel, ‘Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners’, Transl. Pediatr., vol. 7, no. 1, pp. 36–47, Jan. 2018, doi: 10.21037/tp.2017.08.02.
[32] A. Nanda et al., ‘Adverse Effects of Stimulant Interventions for Attention Deficit Hyperactivity Disorder (ADHD): A Comprehensive Systematic Review’, Cureus, vol. 15, no. 9, p. e45995, doi: 10.7759/cureus.45995.
[33] G. Rezaei et al., ‘Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis’, Med. J. Islam. Repub. Iran, vol. 30, p. 325, Feb. 2016, Accessed: Aug. 05, 2025. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898838/
[34] L. Briars and T. Todd, ‘A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder’, J. Pediatr. Pharmacol. Ther. JPPT, vol. 21, no. 3, pp. 192–206, 2016, doi: 10.5863/1551-6776-21.3.192.
[35] M. Döpfner et al., ‘Efficacy of a mobile-based self-directed parent management training for parents of children with attention-deficit/hyperactivity disorder with or without oppositional defiant disorder– a randomized controlled trial’, Eur. Child Adolesc. Psychiatry, June 2025, doi: 10.1007/s00787-025-02799-2.
[36] A.-M. Lange et al., ‘Parent Training for Preschool ADHD in Routine, Specialist Care: A Randomized Controlled Trial’, J. Am. Acad. Child Adolesc. Psychiatry, vol. 57, no. 8, pp. 593–602, Aug. 2018, doi: 10.1016/j.jaac.2018.04.014.
[37] B. T. Ojinna et al., ‘Efficacy of Cognitive Behavioral Therapy and Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: A Systematic Review’, Cureus, vol. 14, no. 12, p. e32647, Dec. 2022, doi: 10.7759/cureus.32647.
[38] T. Banaschewski, K. Becker, M. Döpfner, M. Holtmann, M. Rösler, and M. Romanos, ‘Attention-Deficit/Hyperactivity Disorder’, Dtsch. Ärztebl. Int., vol. 114, no. 9, pp. 149–159, Mar. 2017, doi: 10.3238/arztebl.2017.0149.
[39] R. Zheng, S. Huang, J. Yang, P. Zhao, and E. Li, ‘The therapeutic effects of physical activity on children with attention deficit hyperactivity disorder: A systematic review and meta-analysis’, Medicine (Baltimore), vol. 104, no. 16, p. e42063, Apr. 2025, doi: 10.1097/MD.0000000000042063.
[40] A. Martín-Rodríguez, S. Herrero-Roldán, and V. J. Clemente-Suárez, ‘The Role of Physical Activity in ADHD Management: Diagnostic, Digital and Non-Digital Interventions, and Lifespan Considerations’, Children, vol. 12, no. 3, p. 338, Mar. 2025, doi: 10.3390/children12030338.
[41] E. J. S. Sonuga-Barke et al., ‘Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments’, Am. J. Psychiatry, vol. 170, no. 3, pp. 275–289, Mar. 2013, doi: 10.1176/appi.ajp.2012.12070991.
[42] Y. Khoshbakht, F. Moghtaderi, R. Bidaki, M. Hosseinzadeh, and A. Salehi-Abargouei, ‘The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial’, Eur. J. Nutr., vol. 60, no. 7, pp. 3647–3658, Oct. 2021, doi: 10.1007/s00394-021-02527-x.
[43] F. Abhishek et al., ‘Dietary Interventions and Supplements for Managing Attention-Deficit/Hyperactivity Disorder (ADHD): A Systematic Review of Efficacy and Recommendations’, Cureus, vol. 16, no. 9, p. e69804, doi: 10.7759/cureus.69804.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Michalina Raczkowska, Dominika Szaj, Paulina Strzałkowska, Maciej Hobot, Wojciech Grabski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 136
Number of citations: 0
